Fletcher Payne, Chief Financial Officer at CATALYST BIOSCIENCES, INC. (CBIO), bought 10,000 shares at $2.00 ($20K) on 2015-12-17, disclosed to the SEC on 2015-12-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.